Reversible Pulpitis Clinical Trial
Official title:
Effect of Simvastatin on Success of Pulpotomy in Cariously Exposed Permanent Molars: a Randomized Control Trial
The study will compare the outcome of complete pulpotomy in mature permanent mandibular molars with deep carious lesions by using Mineral Trioxide Aggregate and Simvastatin -alpha tricalcium phosphate as medicament agent
After a thorough history, clinical and radiographic examination with all eligibility confirmation, written informed consent will be taken from the patient after explaining the procedure, its associated risks and benefits. Clinical diagnosis of reversible pulpitis will be established. Complete pulpotomy will be done in both groups. Mineral Trioxide Aggregate and Simvastatin -alpha tricalcium phosphate will be used as pulpotomy agents. Pain analysis will be carried out preoperatively and postoperatively at every 6 hours for 1 day and then every 24 hours till 7 days after the intervention. All the subjects will be followed up for evaluation of clinical and radiographic success at 3, 6 months and 1 year. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05167123 -
Pulp Capping in Primary Molars Using TheraCal (LC)
|
Phase 4 | |
Recruiting |
NCT05144711 -
Management of Deep Carious Lesions in Adults
|
N/A | |
Completed |
NCT01224925 -
RCT of Pulp Capping Over Carious Exposure in Adults
|
N/A | |
Completed |
NCT03284697 -
Direct Pulp Capping With MTA and Calcium Hydroxide.
|
N/A | |
Completed |
NCT03286959 -
Effect of Liners on Pulpal Outcome and Restoration Survival After Partial Caries Excavation
|
N/A | |
Completed |
NCT04167943 -
Conservative Pulp Therapy of Primary Molars Using TheraCAL
|
Phase 3 | |
Enrolling by invitation |
NCT02702505 -
Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT
|
Phase 4 | |
Active, not recruiting |
NCT05878249 -
Role Of Wound Lavage in Direct Pulp Capping Of Permanent Teeth With Carious Exposure
|
N/A | |
Not yet recruiting |
NCT06433297 -
Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars
|
N/A | |
Not yet recruiting |
NCT04617600 -
Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.
|
N/A | |
Terminated |
NCT01622153 -
Electrical and Formocresol Pulpotomy in Primary Molars
|
N/A | |
Active, not recruiting |
NCT03186690 -
Similar Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentineā¢
|
N/A | |
Active, not recruiting |
NCT03071588 -
Assessment of a New Protocol for Indirect Pulp Capping Procedures
|
N/A | |
Active, not recruiting |
NCT02201641 -
Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial
|
Phase 4 | |
Recruiting |
NCT03741816 -
Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars
|
N/A | |
Completed |
NCT04365270 -
Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer
|
Phase 3 | |
Completed |
NCT05145686 -
The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments
|
Phase 1/Phase 2 | |
Completed |
NCT00187837 -
The CAP-1 Trial: Stepwise Excavation Versus One Completed Excavation in Deep Caries
|
N/A | |
Recruiting |
NCT06435065 -
Direct Pulp Capping Agent on Human Pulp Tissue
|
Phase 4 | |
Not yet recruiting |
NCT04807244 -
Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Full Pulpotomy
|
N/A |